Trials / Unknown
UnknownNCT05355610
Vestibular Rehabilitation With Intratympanic Drug Therapy in Meniere's Disease
Objective Vestibular Evaluation & Rehabilitation With Intratympanic Dexamethasone and Gentamicin in Meniere's Disease
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 93 (estimated)
- Sponsor
- Combined Military Hospital Quetta · Academic / Other
- Sex
- All
- Age
- 24 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Intractable symptoms of Meniere's disease will be treated with intratympanic steroids. At the same time intratympanic dexamethasone will be used to rescue hearing
Detailed description
For Alleviation of Intractable symptoms of Meniere's disease will be treated with intratympanic steroids. Measured with pre and post therapy vestibular severity index. At the same time intratympanic dexamethasone will be used to rescue hearing measured with speech reception threshold and speech discrimination threshold
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gentamicin | Intratympanic gentamicin and dexamethasone administered in two doses one week apart |
| DRUG | Dexamethasone | Intratympanic gentamicin and dexamethasone administered in two doses one week apart |
Timeline
- Start date
- 2021-04-01
- Primary completion
- 2022-04-22
- Completion
- 2022-05-30
- First posted
- 2022-05-02
- Last updated
- 2022-05-02
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT05355610. Inclusion in this directory is not an endorsement.